Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT02456402
Eligibility Criteria:
Inclusion Criteria:
* Stable Angina and Unstable angina
* single de novo coronary artery lesions in a single vessel with \> 50% diameter stenosis with a reference diameter \> 2.75mm
* Patients at high risk of bleeding and whom cannot tolerate dual antiplatelet therapy for \> 1 month are inclusion criteria for the study and are listed here:
* Unexplained anemia
* Atrial fibrillation with CHADSVASC \> or equal to 1
* Patients awaiting for non cardiac surgery within a year
* History of massive hemorrhage requiring transfusion
* History of upper GI bleeding
* Malignancy
* Poor compliance with medication
Exclusion Criteria:
* STEMI/NSTEMI within the preceding 72 hours
* Multivessel disease, chronic total occlusion, long lesions and left main disease
* heart failure with ejection fraction \< 35% and/or cardiogenic shock
* Previous history of or planned coronary artery bypass grafting
* life expectancy of less than 1 year
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT02456402
Study Brief:
Protocol Section:
NCT02456402